Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
331
331 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- co-administration of cefepimePhase 32 trials
Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia
- Copper Cu 64 PSMA I&TPhase 32 trials
Curium US LLC · Prostate Cancer, Prostate Adenocarcinoma, Biochemical Recurrence of Malignant Neoplasm of Prostate
- CTX-009Phase 32 trials
Compass Therapeutics · Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer
- CyclosporinPhase 32 trials
Shanghai JMT-Bio Inc. · Primary Membranous Nephropathy
- DWP16001Phase 32 trials
Daewoong Pharmaceutical Co. LTD. · Type 2 Diabetic Nephropathy, T2DM (Type 2 Diabetes Mellitus)
- for organ preservation in transplantationCustodiol-N, CustodiolPhase 32 trials
Dr. F. Köhler Chemie GmbH · Heart Transplantation, Kidney Failure, Liver Failure, Chronic
- HRS-8427Phase 32 trials
Jiangsu HengRui Medicine Co., Ltd. · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP), Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)
- iltamiocelAMDC-USRPhase 32 trials
Cook MyoSite · Stress Urinary Incontinence, Fecal Incontinence
- JADE101Phase 32 trials
Jade Biosciences, Inc. · IgA Nephropathy (IgAN), IgA Nephropathy
- JNJ-101556143Phase 32 trials
Johnson & Johnson (Janssen) · Prostatic Neoplasms
- nacubactamPhase 32 trials
Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia
- Open-Label Extension PLS240Phase 32 trials
Pathalys Pharma · Secondary Hyperparathyroidism, End-stage Kidney Disease (ESKD), End Stage Kidney Disease
- PF-07248144Phase 32 trials
Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- QRX-3EseronatePhase 32 trials
Ebima Clifford Okundaye · Chronic Kidney Diseases, Acute Kidney Injury, Kidney Failure
- RezvilutamidePhase 32 trials
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials
Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus
- RoxadustatFG-4592, ASP1517Phase 32 trials
Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes
- RVX000222apabetalone, RVX-208Phase 32 trials
Resverlogix Corp · Post-Acute COVID-19 Syndrome, Kidney Failure, Chronic
- SAL0120Phase 32 trials
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Chronic Kidney Disease, Uncontrolled Hypertension, Resistant Hypertension
- SHR6508Phase 32 trials
Shanghai Hengrui Pharmaceutical Co., Ltd. · Secondary Hyperparathyroidism, Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
- TMPSMX, Trimethoprim-sulfamethoxazolePhase 32 trials
Locus Biosciences · Urinary Tract Infections, Candidemia, Mycoses
- TR115Phase 32 trials
Tarapeutics Science Inc. · Ovarian Clear Cell Carcinoma, Endometrial Cancer, Stomach Cancer Recurrent
- TS-172Phase 32 trials
Taisho Pharmaceutical Co., Ltd. · Hyperphosphatemia Patients on Hemodialysis
- VepugratinibLY3866288Phase 32 trials
Eli Lilly · Urinary Bladder Neoplasms, Urologic Neoplasms, Receptor, Fibroblast Growth Factor, Type 3
- VX-147Inaxaplin, IXPPhase 32 trials
Vertex Pharmaceuticals · Proteinuric Kidney Disease
- WS016Phase 32 trials
Waterstone Pharmaceutical (Wuhan) Co., LTD. · Hyperkalemia
- XaluritamigAMG 509Phase 32 trials
Amgen · Metastatic Castration-resistant Prostate Cancer
- ZimislecelFormerly known as STx-02, VX-880Phase 32 trials
Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1
- ZuberitamabPhase 32 trials
BioRay Pharmaceutical Co., Ltd. · Primary Membranous Nephropathy
- BCD-131pegdarbepoetin betaPhase 31 trial
Biocad · Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis
- BHV-1400Phase 31 trial
Biohaven Therapeutics Ltd. · IgA Nephropathy
- BMS-986365Phase 31 trial
Bristol Myers Squibb · Metastatic Castration-resistant Prostate Cancer
- DeutenzalutamidePhase 31 trial
AstraZeneca · Metastatic Castration-resistant Prostate Cancer
- DTT106Phase 31 trial
EMS · Prostatic Hyperplasia, Benign, Erectile Dysfunction
- FuzuloparibPhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- HRS-4357Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
- iCM012Phase 31 trial
iCoat Medical AB · Ischemia-reperfusion Injury, Kidney Transplant; Complications
- JNJ-87189401Phase 31 trial
Johnson & Johnson (Janssen) · Metastatic Castration-resistant Prostatic Neoplasms
- matched to PovetaciceptPhase 31 trial
Alpine Immune Sciences Inc, A Subsidiary of Vertex · Immunoglobulin A Nephropathy
- N0728Phase 31 trial
Eurofarma Laboratorios S.A. · Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
- NEMO-103Phase 31 trial
Inventera Inc. · Rotator Cuff Tear, Labral Tear, Rotator Cuff Tendinosis
- New of NiraparibPhase 31 trial
Johnson & Johnson (Janssen) · Castration-Resistant Prostatic Cancer
- QLG1080Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Prostate Cancer
- RinzimetostatORIC-944Phase 31 trial
ORIC Pharmaceuticals · Metastatic Castration Resistant Prostate Cancer
- SasanlimabPF-06801591Phase 31 trial
Pfizer · Non-muscle Invasive Bladder Cancer
- SC0062Phase 31 trial
Biocity Biopharmaceutics Co., Ltd. · IgA Nephropathy (IgAN)
- SefaxersenRO7434656Phase 31 trial
Roche (Genentech) · Primary IgA Nephropathy
- sustained-release gemcitabine-docetaxelNDV-01Phase 31 trial
Relmada Therapeutics, Inc. · Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Urothelial Carcinoma Bladder
- MK-4830Phase 210 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma
- NM8074Phase 28 trials
NovelMed Therapeutics · Paroxysmal Nocturnal Hemoglobinuria, Dermatomyositis, PNH - Paroxysmal Nocturnal Hemoglobinuria
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.